Equity Transfer Agreement between Han Lingzhi and Shandong Global Pharm Group, Ltd. regarding Bozhou Xinghe Pharmaceutical Co., Ltd.
Contract Categories:
Business Finance
›
Purchase Agreements
Summary
This agreement is between Han Lingzhi (the transferor) and Shandong Global Pharm Group, Ltd. (the transferee). Han Lingzhi agrees to transfer a 62% ownership stake, valued at RMB 12.4 million, in Bozhou Xinghe Pharmaceutical Co., Ltd. to Shandong Global Pharm Group, Ltd. The parties have completed the necessary filing procedures for the equity change, and the transfer is subject to the terms of a related Merger and Acquisition Agreement. The agreement was signed on July 4, 2011.
EX-10.17 21 v231159_ex10-17.htm EXHIBIT 10.17
EQUITY TRANSFER AGREEMENT
| Party A (Transferor): | Han Lingzhi |
| ID No.: | 341602197208116069 |
| Party B (Transferee): | Shandong Global Pharm Group, Ltd. |
Party A hereto agrees to transfer its 62% equity interest of RMB 12.4 million in Bozhou Xinghe Pharmaceutical Co., Ltd. to Party B through the negotiation of the two parties.
The two parties handled the filing procedures for equity change.
The detailed provisions for transfer of the two parties shall comply with the Merger and Acquisition Agreement signed hereto.
1
Party A
| Han Lingzhi | ) |
Party B
| Shandong Global Pharm | ) |
| Group, Ltd. | ) |
| Song Yanliang | |
| Representative |
Signing date: July 4, 2011
2
